Patents Assigned to Mabloc, LLC
  • Patent number: 12110319
    Abstract: Antibodies and antigen-binding fragments thereof specific to the YFV E protein and with neutralizing potency against YFV are provided. These antibodies and antigen-binding fragments are useful in treating YFV.
    Type: Grant
    Filed: October 11, 2023
    Date of Patent: October 8, 2024
    Assignee: Mabloc, LLC
    Inventors: Anna Wec, Laura Walker